10-K Decoder · All companies

Celldex Therapeutics, Inc.

CLDX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$1.54M$7.02M−78.1%
Operating income−$287M−$195M−47.3%
Net income−$259M−$158M−63.9%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$82.3M−$73.6M−11.8%
Net income−$75.6M−$67.0M−12.8%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Celldex's revenue in FY2025?
$1.54M in FY2025 (Fiscal year ended Dec 31, 2025), −78.1% vs $7.02M a year earlier, per its 10-K filed Feb 2026.
Was Celldex profitable in FY2025?
No: net income was −$259M and operating income −$287M in FY2025.
What was Celldex's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 5, 2026.